Tonix Pharmaceuticals Holding Corp Stock Nasdaq
Equities
US8902602015
Pharmaceuticals
End-of-day quote
Other stock markets
|
||
- USD | - |
Financials (USD)
Sales 2024 * | 17.3M | Sales 2025 * | 19.2M | Capitalization | 16.1M |
---|---|---|---|---|---|
Net income 2024 * | -75M | Net income 2025 * | -65M | EV / Sales 2024 * | 0.93 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 0.84 x |
P/E ratio 2024 * |
-0.18
x | P/E ratio 2025 * |
-0.15
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.99% |
1st Jan change | Capi. | |
---|---|---|
-4.66% | 86.13B | |
+1.32% | 39.82B | |
-19.27% | 30.42B | |
+57.86% | 25.23B | |
-17.69% | 11.6B | |
-43.00% | 11.51B | |
-9.14% | 11.95B | |
+5.24% | 8.71B | |
-8.42% | 8.12B |